Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell envelope is a sophisticated, multi-layered structure that serves as the primary interface between a bacterium and its environment. It provides structural rigidity, protects against osmotic pressure, and regulates the transport of nutrients and waste. In Gram-positive bacteria, the envelope consists of a thick peptidoglycan layer overlying a single cytoplasmic membrane, whereas Gram-negative bacteria feature a thinner peptidoglycan layer sandwiched between an inner membrane and a unique outer membrane rich in lipopolysaccharides (Silhavy et al., 2010). This structure is vital for bacterial viability and pathogenesis, making it one of the most successful targets in clinical medicine. Antibiotics such as beta-lactams and glycopeptides target the assembly of the peptidoglycan cell wall, while agents like polymyxins and daptomycin target the lipid membranes themselves (Breijyeh et al., 2020). Because the specific components of the cell wall (like peptidoglycan) are absent in human cells, these targets allow for highly selective toxicity against pathogens. However, the emergence of resistance mechanisms, such as modified penicillin-binding proteins or altered membrane charges, poses a significant challenge to current therapies (StatPearls, 2023). Understanding the envelope's composition is crucial for developing new antimicrobial agents that can bypass the outer membrane of Gram-negative 'superbugs'.
Drugs targeting the bacterial cell envelope primarily act by inhibiting peptidoglycan biosynthesis (e.g., beta-lactams and glycopeptides) or by physically disrupting the integrity of the inner or outer membranes (e.g., polymyxins and lipopeptides), leading to osmotic lysis and cell death.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell envelope and membranes.